Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 14, 2020
Reporting Period: Single event date (September 14, 2020)
The filing serves as a notification of an upcoming corporate event rather than a periodic financial report. The Company is an emerging growth company with common stock trading on The NASDAQ Stock Market LLC under the symbol "INMB."
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue figures, profit data, cash flow information, margins, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes
No material changes to financial condition or operations are reported in this document. The filing solely discloses a scheduled management participation in an investor summit.
Guidance, Outlook, and Events
- Upcoming Event: Management will participate in Oppenheimer's Fall Healthcare Life Science & Med Tech Virtual Investor Summit on September 23, 2020.
- Management Commentary: No specific commentary on business outlook, risks, or contingencies is included in this filing.
- Unusual Items: None reported.
Investor Verification Checklist
- Verify the date and agenda of the Oppenheimer Fall Healthcare Life Science & Med Tech Virtual Investor Summit (September 23, 2020).
- Review the attached press release (Exhibit 99.1) for any additional details regarding the summit participation.
- Consult the Company's most recent 10-Q or 10-K filings for current financial metrics, as this 8-K contains no financial data.